New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - midazolam 5 mg/ml;   - solution for injection - 5 mg/ml - active: midazolam 5 mg/ml   excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - conscious sedation before diagnostic or surgical interventions carried out under local anaesthesia (intravenous administration), or in children intranasal or oral administration. long-term sedation in intensive care units (intravenous administration as bolus injection or continuous infusion).

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - midazolam -

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - midazolam -

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - midazolam -

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - midazolam -

European Union - English - EMA (European Medicines Agency)

mediwound germany gmbh - proteolytic enzymes enriched in bromelain - debridement - preparations for treatment of wounds and ulcers - nexobrid is indicated for removal of eschar in adults with deep partial- and full-thickness thermal burns.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - midazolam, quantity: 5 mg - injection, solution - excipient ingredients: hydrochloric acid; sodium chloride; water for injections - intravenously as an agent for conscious sedation prior to short surgical, diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography and cardiac catheterisation, either alone or in conjunction with an opioid analgesic. intravenously for induction of anaesthesia, preliminary to administration of other anaesthetic agents. with the use of an opioid analgesic premedicant, induction of anaesthesia can be attained with a narrower dose range and in a shorter period of time. sedation in intensive care units by intravenous intermittent administration or continuous infusion. intramuscularly for preoperative sedation (induction of sleepiness or drowsiness and relief of apprehension) and to impair memory of perioperative events.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - midazolam -

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - midazolam -

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - midazolam -